leisure time -WSS

leisure time

author：entertainment 2025-09-30 08:00:59 - browse：681

The removal of small amounts of brain tissue from desperately ill patients, done as part of a Mount Sinai research project, triggered alarm bells at the Food and Drug Administration and has raised broader questions about the scientific and ethical justification for live-brain research. Journalist and STAT contributor Katherine Eban joins “The Readout LOUD” podcast to discuss the results of a two-year investigation.

Also on this week’s episode, we discuss Novartis’ effort to acquire MorphoSys, and the latest news on Eli Lilly and Novo Nordisk’s blockbuster obesity drugs with Elaine Chen, the newest member of STAT’s biotech reporting team.

For more on what we cover, here’s STAT’s investigation into the Mount Sinai brain-tissue research project; here’s exclusive reporting on the MorphoSys drug at the center of the Novartis acquisition, and Adam Feuerstein’s take on where it might run off the rails; and here’s STAT’s reporting on Novo Nordisk and its weight loss drug Wegovy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： FDA approves Sage Therapeutics’ rapid

WSS

Flint parents haunted by uncertainty, fears of lead poisoning

Study finds gene variants tied to breast cancer risk in Black women

Alnylam reports growth in sales of rare disease treatments

Late stage cancers on the rise after pandemic delayed screenings

Fentanyl is making it harder to start addiction treatment

Addressing health care workers' trauma can help fight burnout

explore

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

leisure time

Trump demands the U.S. pay no more for drugs than other countries … again

ASCO eve: Let’s set the table for this year's meeting

At least 13 dead in Texas as scorching temps continue

Alnylam reports growth in sales of rare disease treatments

United colonoscopy coverage change 'may cost lives,' doctors say

At flashy new research hub, AstraZeneca lays out ambitious growth goals

The cancer drug shortage isn’t new — and neither are the solutions

CDC recommends RSV monoclonal antibody for infants

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Bird flu surveillance in wastewater gets boost from consortium

leisure time

Questions and answers about ramping up H5N1 bird flu vaccine

FDA scientists endorse Pfizer/BioNTech Covid

Fentanyl is making it harder to start addiction treatment

FDA poised to publish guidelines for clinical trial diversity

CDC recommends RSV monoclonal antibody for infants

Flint parents haunted by uncertainty, fears of lead poisoning

focus

focus

Wikipedia

entertainment